96
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization.

      Science (New York, N.Y.)
      Amino Acid Sequence, Animals, Cell Line, Cyclic AMP-Dependent Protein Kinases, metabolism, Dinoprostone, administration & dosage, pharmacology, Female, Freund's Adjuvant, Glycine, Humans, Inflammation, physiopathology, Male, Mice, Mice, Knockout, Molecular Sequence Data, Neurons, Pain, Patch-Clamp Techniques, Phosphorylation, Posterior Horn Cells, Receptors, Glycine, chemistry, genetics, Signal Transduction, Spinal Cord, Synaptic Transmission, Transfection, Zymosan

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Prostaglandin E2 (PGE2) is a crucial mediator of inflammatory pain sensitization. Here, we demonstrate that inhibition of a specific glycine receptor subtype (GlyR alpha3) by PGE2-induced receptor phosphorylation underlies central inflammatory pain sensitization. We show that GlyR alpha3 is distinctly expressed in superficial layers of the spinal cord dorsal horn. Mice deficient in GlyR alpha3 not only lack the inhibition of glycinergic neurotransmission by PGE2 seen in wild-type mice but also show a reduction in pain sensitization induced by spinal PGE2 injection or peripheral inflammation. Thus, GlyR alpha3 may provide a previously unrecognized molecular target in pain therapy.

          Related collections

          Author and article information

          Comments

          Comment on this article